Comparing 1 vs 2 Hours Post Meal Glucose Monitoring in Gestational Diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the effectiveness of monitoring blood glucose levels 1 hour versus 2 hours after meals in pregnant women diagnosed with Gestational Diabetes Mellitus who require treatment. Participants will be randomly assigned to one of the two monitoring schedules and will undergo a staggered 7-point blood sugar profile. The study aims to follow these patients until delivery to assess treatment adherence and glucose control.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Gestational diabetes diagnosed based on National Institute for Health and Care Excellence guideline
* requiring treatment either with metformin alone or combined with insulin

Exclusion Criteria:

* type 1 and 2 diabetes
* bad obstetrics history
* underlying medical disorders such as Systemic Lupus Erythematosus
* fetal anomaly
* delivery elsewhere

Where it's running

• UKM Medical Center
  Kuala Lumpur, W.Persekutuan, Malaysia Recruiting

Study contacts

• Principal investigator: Rahana Abd Rahman — National University of Malaysia
• Study coordinator: Rahana Abd Rahman
• Email: drrahana@ppukm.ukm.edu.my
• Phone: +60122719985

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Early Glucose Patterns in Pregnant Women at Risk for GDM

  This study tests whether continuous glucose monitoring in early pregnancy can detect dysglycemia before GDM is diagnosed, in women with and without known risk factors.

  Recruiting DCB Research AG · Bern, Canton of Bern · NCT07783178

• Impact of Food Help on Adherence to Cancer Treatment

  This study tests whether providing food assistance helps adults with cancer who have food insecurity stick to their treatment plans.

  Recruiting Virginia Commonwealth University · Richmond, Virginia · NCT07706192

• mHealth tool to boost hormone therapy adherence for Latina breast cancer patients

  A bilingual, culturally tailored smartphone app plus patient navigation is tested to help Latina women on hormone therapy take their medication as prescribed.

  Recruiting The University of Texas Health Science Center at San Antonio · San Antonio, Texas · NCT07706127

• Probiotic-augmented therapy for gestational diabetes

  This trial tests whether adding multistrain probiotics to metformin, insulin, or their combination can improve blood sugar control and inflammation in pregnant women with gestational diabetes.

  Recruiting Riphah International University · Rawalpindi, Punjab Province · NCT07645001

• Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes

  This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.

  Recruiting University of Tennessee Graduate School of Medicine · Knoxville, Tennessee · NCT07565727

• Telenursing to detect and manage side effects from CDK4/6 inhibitors in breast cancer

  This project tests whether scheduled phone or video contacts from trained nurses, added to usual care, help people with breast cancer taking CDK4/6 inhibitors notice and manage side effects earlier and stay on treatment.

  Recruiting Azienda Sanitaria Locale di Asti · Asti, ASTI · NCT07524829

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.